The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Zhuang, Hong Qing ^a   Wang, Jun Jie ^a   Liao, An Yan ^a   Wang, Ji Dong ^a   Zhao, Yong ^b  

^a PEKING UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; COBALT 60; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; IODINE 125; MITOGEN ACTIVATED PROTEIN KINASE; PROPIDIUM IODIDE; RAF PROTEIN; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ANTIBODY DETECTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL ASSAY; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; COLONY FORMING UNIT; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LOW ENERGY RADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; SIGNAL TRANSDUCTION; THERAPY EFFECT; BIOSYNTHESIS; BRACHYTHERAPY; CELL CYCLE; COLON TUMOR; DRUG EFFECT; ENZYMOLOGY; HUMAN; IMMUNOLOGY; PATHOLOGY; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; APOPTOSIS; BRACHYTHERAPY; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; RADIATION DOSAGE; RAF KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 62449210715     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-12     Document Type: Article

References (41)

1. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. R Nath LL Anderson G Luxton KA Weaver JF Williamson AS Meigooni, Med Phys 1995 22 2 209 234 10.1118/1.597458 7565352
2. A purpose built iodine-125 plaque for low dose rate low energy irradiation of cell lines in vitro. EG Aird M Folkard CR Mayes PJ Bownes JM Lawson MC Joiner, Br J Radiol 2001 74 877 56 61 11227778
3. Theoretical analysis of microdosimetric spectra and cluster formation for Pd-103 and I-125 photon emitters. B Reniers S Vynckier F Verhaegen, Int J Radiat Oncol Biol Phys 2004 49 16 3781 3795
4. Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution. Z Chen N Yue X Wang KB Roberts R Peschel R Nath, Int J Radiat Oncol Biol Phys 2000 47 5 1405 1419 10889396
5. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Y Yu LL Anderson Z Li DE Mellenberg R Nath MC Schell FM Waterman A Wu JC Blasko, Med Phys 1999 26 10 2054 2076 10.1118/1.598721 10535622
6. 125I seeds as salvage therapy for re-recurrent rectal carcinoma. J Wang H Yuan J Li W Jiang Y Jiang S Tian, Int J Colorectal Dis 2009 24 4 391 399 10.1007/s00384-008-0628-4 19084969
7. Computed tomography-guided salvage brachytherapy of recurrent large nonresectable familial colo-rectal cancer in the pelvis: case report. PG Koutrouvelis, Technol Cancer Res Treat 2002 1 1 61 64 12614178
8. CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinoma. H Sakurai N Mitsuhashi K Harashima H Muramatsu H Ishikawa Y Kitamoto Y Suzuki JI Saitoh T Nonaka T Akimoto Y Nakayama M Hasegawa T Nakano, Brachytherapy 2004 3 4 222 230 10.1016/j.brachy.2004.09.007 15607154
9. Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma. R Martínez-Monge S Nag EW Martin, Cancer 1999 86 2 236 247 10.1002/(SICI)1097-0142(19990715)86:2〈236::AID-CNCR7〉3.0.CO;2-9 10421259
10. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy. O Coatmeur G Truc I Barillot JC Horiot P Maingon, Radiother Oncol 2004 70 2 177 182 10.1016/j.radonc.2004.01.016 15028405
11. Implantation of iodine-125 seed for head and neck carcinoma. J Wang H Yuan W Ran, Chin J Radiol Med Prot 2006 26 1 56 59
12. Low dose rate brachytherapy in lip carcinoma. C Conill E Verger J Marruecos M Vargas A Biete, Clin Transl Oncol 2007 9 4 251 254 10.1007/s12094-007-0046-z 17462978
13. Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. F Joyce F Burcharth HH Holm I Stroyer, Int J Radiat Oncol Biol Phys 1990 19 4 1049 1052 1698755
14. Interstitial brachytherapy for pancreatic cancer: report of seven cases treated with 125I and a review of the literature. P Montemaggi R Dobelbower F Crucitti F Caracciolo AG Morganti D Smaniotto S Luzi N Cellini, Int J Radiat Oncol Biol Phys 1991 21 451 457 2061121
15. Adjuvant and Neoadjuvant Therapies of Pancreatic Cancer: A Review. J Harris H Bruckner, Int J Gastrointest Cancer 2001 29 1 8 10.1385/IJGC:29:1:01 12754399
16. Development of a rat solid tumor modal for continuous low-dose-rate irradiation studies using 125I and 103Pd sources. R Nath P Bongiorni Z Chen J Gragnano S Rochwell, Brachytherapy 2004 3 3 159 172 10.1016/j.brachy.2004.08.004 15533809
17. Apoptosis induced by low-dose-rate radiation. H Mirzaie-Joniani D Eriksson A Sheikholvaezin A Johansson PO Lofroth L Johansson T Stigbrand, Cancer 94 4 Suppl 1210 1214 11877747
18. Development and validation of radioactive iodine-125 irradiator in vitro. J Wang J Wang H Zhang H Zhuang Y Zhao A Liao, Chin J Radiol Med Protect 2007 27 3 267 271
19. J Sambrook R David, Molecular Cloning America: CSHL Press Third 2000 1235 1262
20. Cell cycle alteration, apoptosis and response of leukemic cell lines to gamma radiation with high- and low-dose rate. J Vávrová M Rezácová D Vokurková J Psutka, Physiol Res 2004 53 3 335 342 15209542
21. Mechanisms of Enhanced Radiation Response following EpidermalGrowth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva). P Chinnaiyan S Huang G Vallabhaneni E Armstrong S Varambally SA Tomlins AM Chinnaiyan PM Harari, Cancer Res 2005 65 8 3328 3335 15833866
22. EGFR Antagonists in Cancer Treatment. F Ciardiello G Tortora, N Engl J Med 2008 358 1160 1174 10.1056/NEJMra0707704 18337605
23. Biology of interactions: antiepidermal growth factor receptor agents. PM Harari GW Allen JA Bonner, J Clin Oncol 2007 25 26 4057 4065 10.1200/JCO.2007.11.8984 17827454
24. 60Co gamma rays. S Lehnert B Reniers F Verhaegen, Int J Radiat Oncol Biol Phys 2005 63 1 224 229 16111593
25. Relative biological effectiveness of 103Pd and 125I photons for continuous low-dose-rate irradiation of Chinese hamster cells. R Nath P Bongiorni Z Chen J Gragnano S Rockwell, Radiat Res 2005 163 5 501 509 10.1667/RR3363 15850411
26. Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic X rays from its constitutive materials. R Taschereau R Roy J Pouliot, Med Phys 2002 29 7 1397 1402 10.1118/1.1485054 12148718
27. Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources. CS Wuu P Kliauga M Zaider HI Amols, Int J Radiat Oncol Biol Phys 1996 36 3 689 697 8948355
28. The response of human glioma cell lines to low-dose radiation exposure. SC Short SA Mitchell P Boulton M Woodcock MC Joiner, Int J Radiat Biol 1999 75 11 1341 1348 10.1080/095530099139214 10597908
29. Apoptosis in HeLa Hep2 cells is induced by low-dose, low-dose-rate radiation. H Mirzaie-Joniani D Eriksson A Johansson PO Lofroth L Johansson KR Ahlstrom T Stigbrand, Radiat Res 2002 158 5 634 40 10.1667/0033-7587(2002) 158[0634:AIHHCI]2.0.CO;2 12385641
30. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures. CR Mitchell MC Joiner, Int J Radiat Biol 2002 78 11 981 990 10.1080/0955300021006589 12456285
31. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. SJ Collis JM Schwaninger AJ Ntambi TW Keller WG Nelson LE Dillehay TL Deweese, J Biol Chem 2004 279 48 49624 49632 10.1074/jbc.M409600200 15377658
32. DNA repair defect in AT cells and their hypersensitivity to low-dose-rate radiation. H Nakamura Y Yasui N Saito A Tachibana K Komatsu K Ishizaki, Radiat Res 2006 165 3 277 282 10.1667/RR3519.1 16494515
33. Early effect of low dose-rate radiation on cultured tumor cells. J Carlsson E Håkansson V Eriksson J Grawe K Wester E Grusell A Montelius H Lundqvist, Cancer Biother Radiopharm 2003 18 4 663 670 10.1089/ 108497803322287754 14503962
34. Apoptosis-ralated gene and protein expression in human lymphoma xenografts after low dose rate radiation using 67Cu-21T-BAT-Lym-1. LA Kroger GL DeNardo PH Gumerlock CY Xiong MD Winthrop XB Shi PC Mack T Leshchinsky, Cancer Biother Radiopharm 2004 16 3 213 225 10.1089/10849780152389401
35. Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation. KC Chan WF Knox A Gandhi DJ Slamon CS Potten NJ Bundred, Br J Surg 2001 88 3 412 418 10.1046/j.1365-2168.2001.01686.x 11260109
36. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. F Ciardiello R Caputo T Troiani G Borriello ER Kandimalla S Agrawal J Mendelsohn AR Bianco G Tortora, Int J Cancer 2001 93 2 172 178 10.1002/ijc.1335 11410862
37. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. CH Baker D Kedar MF McCarty, Am J Pathol 2002 161 929 938 12213721
38. Radiosensitization of malignant glioma cells through overexpression of dominantnegative epidermal growth factor receptor. G Lammering K Valerie PS Lin RB Mikkelsen JN Contessa JP Feden J Farnsworth P Dent RK Schmidt-Ullrich, Clin Cancer Res 2001 7 3 682 690 11297265
39. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. G Lammering TH Hewit WT Hawkins JN Contessa DB Reardon PS Lin K Valerie P Dent RB Kikkelsen RK Schmidt-Ullrich, J Natl Cancer Inst 2001 93 12 921 929 10.1093/jnci/93.12.921 11416113
40. Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives. Z Zhu, Acta Pharmacol Sin 2007 28 9 1476 1493 10.1111/j.1745-7254.2007.00681.x 17723181
41. Epidermal growth factor receptor pathway inhibitors. J Baselga J Cortes, Cancer Chemother Biol Response Modif 2005 22 205 23 16110613